News
The drugmaker Novo Nordisk is slated to report its second-quarter financial results early Wednesday, after shares plunged ...
Muscle and strength loss in human aging, also known as sarcopenia, can result in trouble with balance and walking, according ...
The market is driving prices on GLP-1 drugs down, and an added benefit is lower spending on food.
Levi & Korsinsky is representing the shareholder plaintiff in a suit claiming the Ozempic and Wegovy manufacturer withheld ...
Novo Nordisk (NVO) files additional court cases against vendors selling cheaper semaglutide knockoffs. Read more here.
Weston's downgrade still values Novo Nordisk stock above its current share price of $47 and change, however. Moreover, Novo ...
Hims’ second-quarter revenue fell 7% from a quarter ago. The decline goes beyond weakness in its GLP-1 weight-loss business.
The online weight loss company launches a $119 starter plan using low-dose semaglutide and behavioral coaching to improve ...
When it comes to weight loss, there are a number of tried and true lifestyle changes you can make to help you along the way.
A study published in Cell Metabolism looks at the effects of semaglutide on skeletal muscle mass in mice. Prof Lora Heisler, Director of Research, Rowett Institute, University of Aberdeen, Rowett ...
New lawsuits target pharmacies producing compounded versions of semaglutide ‘under the fake guise of personalization,’ the Danish drugmaker said ...
People using weight loss medication have been told it's not a "quick fix" with many at risk of regaining their lost weight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results